Indonesia is moving to build its own healthcare AI stack, with health technology company Articura signing memorandums of understanding with five organizations to develop the country’s Sovereign Healthcare AI Platform. The effort is designed to keep national control over health data while introducing AI across the archipelago’s health system.
The initial network includes Prof. Dr. Mahar Mardjono National Brain Center Hospital (RSPON), Indonesia’s national referral center for brain and neurological care; the Faculty of Pharmacy at Universitas Padjadjaran; pediatric care provider Axis Perifer Sentral; primary care provider Fokus Medika; and Orbiva Limited, a subsidiary of Hong Kong-listed Home Control International.
RSPON will provide specialist clinical leadership, the university will contribute pharmaceutical and research expertise, and the two care providers will share practical experience. Orbiva becomes the consortium’s first industry partner, contributing international experience in healthcare AI and AI-enabled home care.
Articura separately unveiled plans for a National AI Healthcare Lab to serve as a shared test bed for the country’s emerging AI community. Clinicians, universities and technology partners would use it to build models, assess healthcare use cases, run professional training and advance promising ideas toward patient care. Early capabilities draw on Articura’s existing AI infrastructure and modular clinical software, spanning documentation, decision support, hospital operations and remote monitoring.
The company says the network will prioritize clinical safety, human oversight and data sovereignty. Articura director Nathan Tirtana said he hopes the initiative marks the start of an AI-driven transformation that streamlines operations and gives doctors more time to care for patients. Orbiva plans to launch health and wellness products through a priority pilot in Indonesia before a potential Southeast Asia expansion.
